December 18, 2024

Darzalex May Delay Myeloma in High-Risk Patients

For the first time, we have a treatment option that can significantly delay or prevent the progression to active disease."

December 11, 2024

Triple-Drug Combos Show High Response Rates

Cutting-edge triple-drug therapies for leukemia discussed at the American Society of Hematology meeting show promising results in achieving remission and managing residual disease.